InvestorsObserver
×
News Home

Is Alpine Immune Sciences Inc (ALPN) Stock at the Top of the Biotechnology Industry?

Monday, November 13, 2023 10:44 AM | InvestorsObserver Analysts

Mentioned in this article

Is Alpine Immune Sciences Inc (ALPN) Stock at the Top of the Biotechnology Industry?

Alpine Immune Sciences Inc (ALPN) is near the top in its industry group according to InvestorsObserver. ALPN gets an overall rating of 89. That means it scores higher than 89 percent of stocks. Alpine Immune Sciences Inc gets a 99 rank in the Biotechnology industry. Biotechnology is number 51 out of 148 industries.

Overall Score - 89
ALPN has an Overall Score of 89. Find out what this means to you and get the rest of the rankings on ALPN!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Alpine Immune Sciences Inc Stock Today?

Alpine Immune Sciences Inc (ALPN) stock is trading at $11.33 as of 10:36 AM on Monday, Nov 13, a decline of -$0.89, or -7.28% from the previous closing price of $12.22. The stock has traded between $10.80 and $12.06 so far today. Volume today is low. So far 122,498 shares have traded compared to average volume of 845,172 shares. Click Here to get the full Stock Report for Alpine Immune Sciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App